The MyCell Process Samples of either peripheral blood or skin samples are received from the customer, typically as PBMC isolates . These cells are reprogrammed using a footprint-free episomal method to produce an expandable population of iPS cells. Genetic engineering can be included in the project scope to produce your desired genotype. The iPS Cells are then differentiated into a range of terminally differentiated cell types. Please contact us for additional details and to discuss the specifics of your project.
{}